The infant and childhood immunization program in Canada has led to extraordinary decreases in serious infections with diphtheria, tetanus, pertussis, polio, Haemophilus influenzae type b, hepatitis B, measles, mumps and rubella. There is a danger that this successful immunization program may lead to complacency about vaccine preventable illnesses such that parents, and sometimes physicians, may become too focused on potential adverse events of vaccination and lose sight of the serious and sometimes even fatal consequences of the disease being prevented. Physicians and parents need reliable accurate information on true contraindications so that opportunities to immunize an infant or child are not missed. In fact, there are very few true contraindications. Deferral or delay of immunization based on misconceptions about contraindications puts an infant or child at risk. The following tables summarize the answers to the most frequently raised questions about contraindications. Tables 1 to 3 are based upon recommendations from the National Advisory Committee on Immunization (1) and the American Advisory Committee on Immunization (2). Additional information written for parents is available in the publication entitled, Your Child’s Best Shot (3).
TABLE 1:
Symptom or condition | Contraindication |
---|---|
Allergy | |
Anaphylactic (life-threatening) allergy to: | |
a) Previous dose of vaccine | That vaccine |
b) Neomycin | Inactivated polio vaccine (IPV), DtaP-IPV-Haemophilus influenzae type b (Pentacel, Aventis Pasteur, Toronto, Ontario), measles-mumps-rubella (MMR) vaccine and varicella vaccine |
c) Gelatin | Varicella vaccine and MMR vaccine |
d) Baker’s yeast | Hepatitis B vaccine |
e) Egg ingestion | Influenza vaccine |
f) Streptomycin | IPV |
Immunodeficient state | |
a) Recipient | |
• congenital immunodeficiency, eg, severe combined immunodeficiency | MMR vaccine, varicella vaccine, oral polio vaccine (OPV)* and bacille Calmette-Guérin (BCG) vaccine |
• acquired immunodeficiency, eg, HIV | OPV*, BCG vaccine and varicella vaccine; precaution with MMR |
• immunosuppression, eg, acute lymphoblastic leukemia on chemotherapy | MMR vaccine, varicella vaccine, BCG vaccine and OPV* |
b) Household contacts | |
• congenital immunodeficiency | OPV* |
• HIV | OPV* |
c) Systemic steroids, high dose | Defer MMR, varicella vaccine, BCG vaccine and OPV* |
Pregnancy | MMR and varicella vaccine |
OPV use is no longer recommended in Canada due to the risk, albeit low, of paralysis; IPV has no such associated risk. DTaP Diphtheria, tetanus, acellular pertussis
TABLE 3:
Symptom or condition | Action |
---|---|
Mild to moderate local reaction to previous injection of vaccine | Immunize |
Mild acute illness with or without fever | Immunize |
Currently taking antibiotics | Immunize |
Recovering from an acute illness | Immunize |
Premature infant | Immunize on time – do NOT delay |
Recent exposure to an infectious disease | Immunize |
Personal or family history of allergy to | |
Penicillin | Immunize |
Duck meat, duck feathers | Immunize |
Molds, grasses, pollens, etc | Immunize |
Eggs | Immunize except for influenza vaccine; NO contraindication to measles-mumps-rubella (MMR) vaccine |
Tuberculosis (TB) or positive TB skin test | Immunize even with MMR and varicella vaccine |
Simultaneous TB skin test | Immunize even with MMR and varicella vaccine |
Fever 40.5°C or higher after first dose of DTP or DtaP | Immunize, give acetaminophen |
Family history of sudden infant death syndrome | Immunize |
Seizure within 48 h of the prior dose of DTP or DtaP | Immunize; give acetaminophen if seizure accompanied by fevers |
Family history of seizures | Immunize |
Persistent inconsolable crying 3 h or more within 48 h after prior dose of DTA or DtaP | Immunize |
Pregnancy | Immunize with tetanus, hepatitis B, influenza and inactivated polio vaccines as required |
History of Haemophilus influenzae type b disease | Immunize Haemophilus influenzae type b vaccine |
Hypotonic-hyporesponsive state within 48 h after prior dose of DtaP containing vaccine | Not necessary to defer because episodes may occur with both DT, DTaP; continued immunization with all antigens is recommended |
aP Acellular pertussis; D Diphtheria; P Pertussis; T Tetanus
TABLE 2:
Symptom or condition | Precaution or action |
---|---|
Moderate or severe illness with or without fever | Defer only if the child is NOT in immediate danger of exposure to the disease or the child is likely to return to continue immunization in a timely fashion |
Recent immunoglobulin administration | Intravenous and intramuscular gammaglobulin can interfere with measles-mumps-rubella (MMR) vaccine and varicella vaccine |
Delay MMR three to 10 months; time depends upon immunoglobulin amount | |
Delay varicella vaccine for five months if intravenous immune globulin (IVIG) and varicella immune globulin (VZIG) | |
Pregnancy | Defer MMR and varicella vaccine until immediate postpartum |
Footnotes
INFECTIOUS DISEASES AND IMMUNIZATION COMMITTEE
Members: Drs Upton Allen, The Hospital for Sick Children, Toronto, Ontario; H Dele Davies, Division of Infectious Diseases, Alberta Children’s Hospital, Calgary, Alberta; Gilles Delage, Laboratoire de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec (chair); Joanne Embree, The University of Manitoba, Winnipeg, Manitoba; Mireille Lemay, Department of Infectious Diseases, Sainte-Justine Hospital, Montréal, Québec; Charles Morin, Complexe hospitalier Sagamie, Chicoutimi, Québec (director responsible); David Speert, Division of Infectious and Immunological Diseases, University of British Columbia, Vancouver, British Columbia; Ben Tan, Division of Infectious Diseases, Royal University Hospital, University of Saskatchewan, Saskatoon, Saskatchewan
Consultants: Drs Noni MacDonald, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia (principal author); Victor Marchessault, Cumberland, Ontario
Liaisons: Drs Susan King, Division of Infectious Diseases, The Hospital for Sick Children, Toronto, Ontario (Canadian Paediatric AIDS Research Group); Scott Halperin, Department of Pediatrics, IWK-Grace Health Centre, Halifax, Nova Scotia (IMPACT); Monique Landry, Direction de la santé publique de Laval, Laval, Québec (Public Health); Larry Pickering, Centre for Paediatric Research, Norfolk, Virginia (American Academy of Pediatrics); John Waters, Alberta Health, Edmonton, Alberta (Epidemiology)
REFERENCES
- 1.National Advisory Committee on Immunization . Canadian Immunization Guide. 5th edn. Ottawa: Health Canada; 1998. [Google Scholar]
- 2.Recommended childhood immunization schedule – United States, 1999. MMWR Morb Mortal Wkly Rep. 1999;48(01):12–6. [PubMed] [Google Scholar]
- 3.Canadian Paediatric Society . Your Child’s Best Shot: A Parent’s Guide To Vaccination. Ottawa: Canadian Paediatric Society; 1997. [Google Scholar]